Aktiesnakken — April 2020
-
jeg tror heller ikke det bliver værre end det, men værste fald er altså 100%, sådan er det altid. Tag en total krig mellem Nato og Rusland+Kina, så skal du se løjer på de boligpriser. Men Corona alene holder sig nok til de 20%, eller bedre. Men nogle er jo belånt 95%, andre har ikke vedligeholdt huset .......
-
God morgen.
-
Palma company preparing clinical trials of Covid-19 inhibitor
Laminar Pharmaceuticals, a biopharmaceutical company based at ParcBit in Palma and in Massachusetts, is preparing a clinical study to treat Covid-19. Pablo Escribá, professor of biology at the University of the Balearic Islands and founder of Laminar, says that the study could begin in a few months. It will be into molecules that inhibit fusion of the virus membrane.
Majorca Daily Bulletin (www.majorcadailybulletin.com)
-
Cedars-Sinai sees early promis in Covid-19 treatment study. https://laist.com/latest/post/20200411/remdesivir-clinical-trial-cedars-sinai
-
bibob...Nu har jeg fået rigeligt med morgenkaffe.
-
-
Ovenstående link til Gileads lille 53 pts studie er der linket til flere gange. Det giver et vist håb. Men vi afventer nu 2 større kinesiske fase 3 studier med kontrolgruppe. Read out meget snart. Og 2 endnu større Gilead studier. Read out i næste md.
-
Gilead har udvidet sine studier fra 600 til 1600 pts og fra 400 til 2400 pts for hhv moderat og svær covid19. https://www.fiercebiotech.com/biotech/gilead-supersizes-remdesivir-trials-changes-primary-endpoint
-
Ser ud til at det ene kinesiske studie (svær covid19) er stoppet: A Chinese trial of Gilead Sciences Inc.’s antiviral drug remdesivir was stopped after failing to enrol enough patients with severe symptoms, the company’s Chief Executive Officer Daniel O’Day wrote in an open letter dated April 10.
China previously said it would announce the results of two remdesivir trials for patients with mild to severe symptoms on April 27.
-
The discontinuation of the severe patient trial came as the number of cases dropped in China. “The publication of data from the China remdesivir trials rests with the Chinese investigators, but we have been informed that the study in patients with severe symptoms was stopped due to stalled enrollment,” O’Day said
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind